Mybacs in a €5.6 million equity round with NaturalX Health Ventures, Wenvest Capital, SevenVentures, Global Founders Capital (GFC) and Joyance Partners Biotech Health services Pharma Investments 22 October 2023 Share:
Round value (USD): 5.99m Round investors: Global Founders Capital (GFC) Joyance Partners WENVEST Capital SevenVentures G-Fund NaturalX Health Ventures Company: Mybacs Industry: Biotech Health services Pharma
Nouscom with a $7.6m series C extension backed by Angelini Ventures Biotech Health services Pharma Investments 12 March 2024
Biolytica raised a CHF 5.25 seed round from the Maximon Longevity Co-Investment Fund.. AI (big data) Biotech Competitive Intelligence Health services Software Services Investments 30 April 2023